OncoGenex is a leader in the development of novel therapeutics that target important mechanisms of treatment resistance in cancer. We are committed to the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.
Bothell, US
41 (est)+18%
OncoGenex has headquartered in Bothell, US

Key People at OncoGenex

Scott Cormack

Scott Cormack

President & Chief Executive Officer
David V. Smith

David V. Smith


OncoGenex Locations

Bothell, US
Vancouver, CA

OncoGenex Metrics

OncoGenex Summary

Market capitalization

$14 M

Closing share price

OncoGenex's latest market capitalization is $14 M.

OncoGenex Market Value History

7% of current employees of OncoGenex are female and 93% are male.

OncoGenex Company Life

You may also be interested in